Ellen Kurek

News
Efficacy of Oral Etoposide Among Patients With Recurrent or Refractory Epithelial Ovarian Cancer
05/10/2022
The administration of oral etoposide at a dose of 50 mg/m2 showed fairish oncologic outcomes with manageable toxicity among patients with recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
The administration of oral etoposide at a dose of 50 mg/m2 showed fairish oncologic outcomes with manageable toxicity among patients with recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
The administration of oral...
05/10/2022
Journal of Clinical Pathways
News
Treatment Strategies for Advanced Classic Hodgkin Lymphoma
07/08/2022
Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.
Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.
Researchers discuss strategies...
07/08/2022
Journal of Clinical Pathways
News
For Patients at High Risk of Hereditary Cancer, Automated Alerts in EHRs May Increase Rates of Genetic Testing, But Implementation Barriers Impede Their Use
05/27/2022
Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.
Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.
Automated alerts providing...
05/27/2022
Journal of Clinical Pathways
News
Experts Review Current Management of Advanced Cervical Cancer
05/27/2022
Researchers describe the epidemiology, treatment, and issues in survivorship facing patients with advanced cervical cancer.
Researchers describe the epidemiology, treatment, and issues in survivorship facing patients with advanced cervical cancer.
Researchers describe the...
05/27/2022
Journal of Clinical Pathways
News
Genomic Assays Aid Individualized Treatment Decision-Making for HR–Positive, HER2–Negative Breast Cancer
04/14/2022
Greater reliance on genomic assays has reduced the use of adjuvant chemotherapy in women with early-stage, HR–positive, HER2–negative breast cancer who are free of axillary node disease and at low genomic risk, according to a recent study.
Greater reliance on genomic assays has reduced the use of adjuvant chemotherapy in women with early-stage, HR–positive, HER2–negative breast cancer who are free of axillary node disease and at low genomic risk, according to a recent study.
Greater reliance on genomic...
04/14/2022
Journal of Clinical Pathways
News
Outcomes of Treatment With Cancer Biosimilars Found Equal to Those of the Reference Drug in Harvard Systematic Review and Meta-Analysis
05/11/2022
Study findings show that results of rigorous clinical evaluation of cancer drug biosimilars were statistically indistinguishable when compared with the results of evaluations of the reference drug across subgroups of drugs, cancer types, and...
Study findings show that results of rigorous clinical evaluation of cancer drug biosimilars were statistically indistinguishable when compared with the results of evaluations of the reference drug across subgroups of drugs, cancer types, and...
Study findings show that results...
05/11/2022
Journal of Clinical Pathways
News
Costs Associated With the Use of a Health System Specialty Pharmacy Health Care for Medicare Advantage Beneficiaries
05/11/2022
Use of a health system specialty pharmacy may be associated with a lower health care cost, according to a retrospective cohort study that examined Medicare Advantage beneficiaries' medical and pharmacy claims from 2018 and 2019.
Use of a health system specialty pharmacy may be associated with a lower health care cost, according to a retrospective cohort study that examined Medicare Advantage beneficiaries' medical and pharmacy claims from 2018 and 2019.
Use of a health system specialty...
05/11/2022
Journal of Clinical Pathways
News
Defining the Notion of Value in Oncology Treatment
07/07/2022
A recent article discusses oncology-specific considerations when assessing elements of value, offering some background on the nature and development of quality-adjusted life-years as a part of cost-effectiveness analyses and some of their key...
A recent article discusses oncology-specific considerations when assessing elements of value, offering some background on the nature and development of quality-adjusted life-years as a part of cost-effectiveness analyses and some of their key...
A recent article discusses...
07/07/2022
Journal of Clinical Pathways
News
Assessing Risk Factors for Progression Among Patients With Advanced Ovarian Cancer After Response to First-line Platinum-Based Chemotherapy
05/31/2022
Multiple factors were associated with shorter time to next treatment or overall survival in a recent retrospective real-world analysis on patients with ovarian cancer.
Multiple factors were associated with shorter time to next treatment or overall survival in a recent retrospective real-world analysis on patients with ovarian cancer.
Multiple factors were associated...
05/31/2022
Journal of Clinical Pathways
News
Survey Explores Prescriber Perceptions and Preferences Regarding First Line Therapy for MCL
07/27/2022
A survey evaluated first-line therapy preferences for treatment-naïve patients with MCL in routine practice and perceptions surrounding benefits and risks of the lenalidomide plus rituximab plus venetoclax triplet regimen.
A survey evaluated first-line therapy preferences for treatment-naïve patients with MCL in routine practice and perceptions surrounding benefits and risks of the lenalidomide plus rituximab plus venetoclax triplet regimen.
A survey evaluated first-line...
07/27/2022
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use